Page 5 - 2019_01-Haematologica-web

Table of Contents
Volume 104, Issue 1: January 2019
Cover Figure
haematologica Journal of the Ferrata Storti Foundation
Bone marrow smear showing hematogones in a 5-year old boy 3 months after allogeneic cord blood transplantation performed for T- lymphoblastic leukemia relapse. Courtesy of Prof. Rosangela Invernizzi.
Editorials
1 Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia Juerg Schwaller
3 New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches
Michal Bar-Natan and Ronald Hoffman
7 Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come Johann Hitzler and Elihu Estey
9 Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia Candida Vitale and Alessandra Ferrajoli
Review Articles
13 Peering through zebrafish to understand inherited bone marrow failure syndromes Usua Oyarbide et al.
25 Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma David Qualls and Jeremy S. Abramson
Articles
Hematopoiesis
35 The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells Deborah Ingenhag et al.
Iron Metabolism & its Disorders
47 Macrophage ferroportin is essential for stromal cell proliferation in wound healing Stefania Recalcati et al.
Myelodysplastic Syndromes
59 Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome
Julia Stomper et al.
Myeloproliferative Neoplasms
70 Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression Alexandre Guy et al.
Chronic Myeloid Leukemia
82 Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells
Manuela Spagnuolo et al.
93 Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
Timothy P. Hughes et al.
Haematologica 2019; vol. 104 no. 1 - January 2019 http://www.haematologica.org/